Synthon BV Appoints Anish Mehta as Chief Executive Officer and Member of the Board of Directors
(0) The Supervisory Board of Synthon BV, an international, science-centered pharmaceutical company specialized in developing and manufacturing high-quality generic and hybrid medicines for patients around the world, is pleased to announce that Anish Mehta is appointed as Chief Executive Officer and member of the Board of Directors, effective immediately. "We are delighted to welcome Anish to Synthon", said Hans Stols, Executive Chairman. "Anish's successful track record, deep industry expertise and his energetic and result-driven personality will help Synthon to continue delivering on our pur...
Source: finanznachrichten.de